Security key
98420P308
Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 81,765,290
- Total 13F value
- $76,033,381
- Share change
- -88,824
- SEC-reported price per share
- $0.93
- Number of holders
- 19
- Value change
- -$53,515
- Number of buys
- 5
- Number of sells
- 5
- Shares outstanding
- 140,036,400
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
19
Top holders
10
XTNT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Xtant Medical Holdings, Inc. SEC filings
Xtant Medical Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420P308
Recent filing periods:
Ownership snapshot
Top reported holders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F
Lead comparable stake: 52%
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 52%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
52%
Altium Capital Management LLC
4.4%
VANGUARD GROUP INC
0.91%
RENAISSANCE TECHNOLOGIES LLC
0.43%
Crescent Grove Advisors, LLC
0.19%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
52%
|
$46,610,552
73,114,592 shares
|
— | 31 Mar 2023 |
| Altium Capital Management LLC |
13F
Company
|
4.4%
|
$3,970,069
6,227,559 shares
|
— | 31 Mar 2023 |
| VANGUARD GROUP INC |
13F
Company
|
0.91%
|
$815,396
1,279,052 shares
|
— | 31 Mar 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.43%
|
$384,000
602,810 shares
|
— | 31 Mar 2023 |
| Crescent Grove Advisors, LLC |
13F
Company
|
0.19%
|
$167,040
262,024 shares
|
— | 31 Mar 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.08%
|
$72,994
114,500 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
81,765,290
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
21
Q2 2023 holders
19
Holder diff
-2
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend